← Back to patent-cliff list
CAS 75-21-8
oxirane
Codes：PRUC-004
Application context (from source-drug indications)
便秘琥珀酸普芦卡必利术后并发症琥珀酸普芦卡必利肠内喂养不耐受琥珀酸普芦卡必利阿片类药物引起的便秘琥珀酸普芦卡必利疼痛琥珀酸普芦卡必利假性肠梗阻琥珀酸普芦卡必利
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 琥珀酸普芦卡必利Prucalopride Succinate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-methoxyaniline→pivaloyl chloride→N-(3-methoxyphenyl)pivalamide→oxirane→N-(2-(2-hydroxyethyl)-3-methoxyphenyl)pivalamide→2,3-dihydrobenzofuran-4-amine→5-chloro-2,3-dihydrobenzofuran-4-amine→7-bromo-5-chloro-2,3-dihydrobenzofuran-4-amine→4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid→1-(3-methoxypropyl)piperidin-4-amine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.